Launch of Healthcare Business Through Joint Venture Between ORIX and the Resorttrust Group

TOKYO, Japan - May 13, 2016 - ORIX Corporation ("ORIX"), a leading integrated financial services group, today announced that it is going to start its own healthcare business through a joint venture company Kosei Co., Ltd. ("Kosei") it established with HIMEDIC, Inc. ("HIMEDIC"), a wholly-owned consolidated subsidiary of Resorttrust Inc. ("Resorttrust"). Concurrently with this announcement, Kosei today concluded an outsourcing service agreement with Shinkokai Medical Corporation ("Shinkokai"), and it will commence to provide medical administration support services at the nine Shinkokai clinics on May 16, 2016.

The Resorttrust Group, with its main business being the operation of luxury membership resort "XIV" and "Baycourt Club", operates "Grand HIMEDIC Club," a membership medical support club offering highly accurate medical check and other services in a relaxing ambience. The Resorttrust Group also supports operations for Tokyo Midtown Medical Center ("Midtown Clinic"), a facility that runs in partnership with Johns Hopkins Medicine International, a highly regarded medical company in the US. In the "Next 40" Medium-term Management Plan, Resorttrust plans to further grow the established "Membership Resort Business" and expand the "Medical and Senior Lifestyle Businesses," as well as develop peripheral businesses by creating new businesses and expanding domains, customer segments and business development areas.

Through support services for Shinkokai under the joint venture with ORIX, the Resorttrust Group seeks not only to expand the scale of medical check businesses being developed by Midtown Clinic and others, but also plans to provide new customer value on a broader stage through expansion of business domains and customer segments. This entails generating synergies with established businesses, for example through expansion of existing cosmetics and supplement marketing networks, and introduction of remote reading for diagnostic imaging.

The ORIX Group is engaged in a wide range of businesses in the healthcare and nursing care fields, including leasing and finance services, and rental services for vehicles fitted with CT and MRI facilities towards medical companies, and also operation of approximately 30 senior housing facilities in the Tokyo metropolitan and Kansai areas. In December 2014, it strengthened its management platform by taking a capital stake in INNOMEDICS Medical Instruments Inc., a company that markets and distributes high-precision medical equipment. Through this joint venture, ORIX plans to support Shinkokai's management through outsourcing services, and to establish its own profile as a healthcare service provider by deepening its understanding of the medical and medical check businesses, which are expected to grow significantly in years ahead.

Going forward, through joint effort with Resorttrust, ORIX will aim to expand its outsourcing services business towards medical companies.

Contact Information:
ORIX Corporation
Corporate Planning Department
Tel: +81-3-3435-3121

About ORIX:
ORIX Corporation (TSE: 8591; NYSE: IX) is a financial services group which provides innovative products and services to its customers by constantly pursuing new businesses. Established in 1964, from its start in the leasing business, ORIX has advanced into neighboring fields and at present has expanded into the lending, investment, life insurance, banking, asset management, automobile-related, real estate and environment and energy-related businesses. Since its first overseas expansion into Hong Kong in 1971, ORIX has spread its business globally by establishing locations in a total of 36 countries and regions across the world. Moving forward, ORIX aims to contribute to society while continuing to capture new business opportunities. For more details, please visit our website: http://www.orix.co.jp/grp/en/

Caution Concerning Forward Looking Statements:
These documents may contain forward-looking statements about expected future events and financial results that involve risks and uncertainties. Such statements are based on our current expectations and are subject to uncertainties and risks that could cause actual results to differ materially from those described in the forward-looking statements. Factors that could cause such a difference include, but are not limited to, those described under "Risk Factors" in the Company's annual report on Form 20-F filed with the United States Securities and Exchange Commission and under "4. Risk Factors" of the "Summary of Consolidated Financial Results" of the "Consolidated Financial Results April 1, 2015 - March 31, 2016."